Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor software release rather than a content change.
    Difference
    0.0%
    Check dated 2026-06-08T14:51:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows the latest revision as v3.5.4, replacing the previous v3.5.3 in the revision history.
    Difference
    0.0%
    Check dated 2026-05-18T03:30:42.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a website release update rather than any change to the clinical trial study details.
    Difference
    0.0%
    Check dated 2026-04-26T13:30:48.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T04:54:30.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T08:44:58.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T18:22:21.000Z thumbnail image

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.